These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 175087)

  • 1. Responsiveness to glucagon in fetal hearts. Species variability and apparent disparities between changes in beating, adenylate cyclase activation, and cyclic AMP concentration.
    Wildenthal K; Allen DO; Karlsson J; Wakeland JR; Clark CM
    J Clin Invest; 1976 Mar; 57(3):551-8. PubMed ID: 175087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of a phosphodiesterase inhibitor on the chronotropic effects of glucagon and norepinephrine in fetal mouse hearts.
    Wildenthal K; Wakeland JR
    J Pharmacol Exp Ther; 1979 Nov; 211(2):350-2. PubMed ID: 574159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturation of responsiveness to cardioactive drugs. Differential effects of acetylcholine, norepinephrine, theophylline, tyramine, glucagon, and dibutyryl cyclic AMP on atrial rate in hearts of fetal mice.
    Wildenthal K
    J Clin Invest; 1973 Sep; 52(9):2250-8. PubMed ID: 4353775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of glucagon sensitivity in neonatal rat liver.
    Vinicor F; Higdon G; Clark JF; Clark CM
    J Clin Invest; 1976 Sep; 58(3):571-8. PubMed ID: 956386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epinephrine, cyclic AMP, calcium, and myocardial contractility.
    Williamson JR; Schaffer S
    Recent Adv Stud Cardiac Struct Metab; 1976; 9():205-23. PubMed ID: 176696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forskolin and myocardial function in the normal, ischemic and reperfused rat heart.
    Hearse DJ; Zucchi R; Buschmans E; Manning AS
    Can J Cardiol; 1986; 2(5):303-12. PubMed ID: 3021303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that cyclic AMP is not involved in the chronotropic action of glucagon in the adult mouse heart.
    Clark CM
    Endocrinology; 1976 Jul; 99(1):23-9. PubMed ID: 181238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of guanylylimidodiphosphate-dependent activation of adenylate cyclase by glucagon in the neonatal rat heart.
    Yount EA; Clark JF; Clark CM
    Pediatr Res; 1976 Oct; 10(10):851-4. PubMed ID: 972786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.
    Böhm M; Brückner R; Hackbarth I; Haubitz B; Linhart R; Meyer W; Schmidt B; Schmitz W; Scholz H
    J Pharmacol Exp Ther; 1984 Aug; 230(2):483-92. PubMed ID: 6086891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of experimental heart failure on the capacity of glucagon to augment myocardial contractility and activate adenyl cyclase.
    Gold HK; Prindle KH; Levey GS; Epstein SE
    J Clin Invest; 1970 May; 49(5):999-1006. PubMed ID: 5441551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for delayed development of the glucagon receptor of adenylate cyclase in the fetal and neonatal rat heart.
    Clark CM; Beatty B; Allen DO
    J Clin Invest; 1973 May; 52(5):1018-25. PubMed ID: 4349483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forskolin: a unique diterpene activator of cyclic AMP-generating systems.
    Seamon KB; Daly JW
    J Cyclic Nucleotide Res; 1981; 7(4):201-24. PubMed ID: 6278005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of glucagon-induced changes in rate, contractility and cyclic AMP levels in isolated cardiac preparations of the rat and guinea pig.
    MacLeod KM; Rodgers RL; McNeill JH
    J Pharmacol Exp Ther; 1981 Jun; 217(3):798-804. PubMed ID: 6262497
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase.
    Méry PF; Brechler V; Pavoine C; Pecker F; Fischmeister R
    Nature; 1990 May; 345(6271):158-61. PubMed ID: 2159595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced sensitivity of the hepatic adenylate cyclase-cyclic AMP system to glucagon during sustained hormonal stimulation.
    DeRubertis FR; Craven P
    J Clin Invest; 1976 Feb; 57(2):435-43. PubMed ID: 176180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of two signal-transduction systems in hepatocytes by glucagon.
    Wakelam MJ; Murphy GJ; Hruby VJ; Houslay MD
    Nature; 1986 Sep 4-10; 323(6083):68-71. PubMed ID: 3018586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tolbutamide on contractility and cyclic adenosine 3':5'-monophosphate concentration in the intact beating rat heart.
    Brown JD; Brown ME
    J Pharmacol Exp Ther; 1977 Jan; 200(1):166-73. PubMed ID: 189007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in some metabolic effects of isoprenaline and glucagon in normotensive and spontaneously hypertensive rats.
    Staneva-Stoycheva D; Bogoslovova T
    Acta Physiol Pharmacol Bulg; 1976; 2(4):40-5. PubMed ID: 196481
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of glucagon on rat cardiac cyclic AMP, phosphorylase a and force of contraction.
    Brunt ME; McNeill JH
    Arch Int Pharmacodyn Ther; 1978 May; 233(1):42-52. PubMed ID: 210728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.